Identification of natural killer cell receptor phenotypes associated with leukemia.
about
The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?Natural Killer Cells for Therapy of LeukemiaKiller immunoglobulin-like receptors and tumor immunityNatural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).Low CD4+ T cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands.Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothersNK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease.MHC class I molecules and KIRs in human history, health and survival.HLA associations with nasopharyngeal carcinoma.KIR repertory in patients with hematopoietic diseases and healthy family membersThe Yin and Yang of HLA and KIR in human diseaseNatural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease.NK cell receptors and their ligands in leukemia.KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer.The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia.Immunotherapy prospects for acute myeloid leukaemia.Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity.Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands.Natural killer cell immune escape in acute myeloid leukemia.NK cells: key to success of DC-based cancer vaccines?The role of KIR genes and ligands in leukemia surveillance.Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies.Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma.Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells.Modification of Expanded NK Cells with Chimeric Antigen Receptor mRNA for Adoptive Cellular Therapy.KIR-HLA profiling shows presence of higher frequencies of strong inhibitory KIR-ligands among prognostically poor risk AML patients.Investigation of killer cell immunoglobulin-like receptors KIR2DL2 and KIR2DL3 diversity and identification of ten novel KIR2DL3 alleles in the Chinese Han population.Natural killer cell receptor repertoire is comparable amongst newly diagnosed acute myeloid leukemia of different French-American-British subtypes, risk categories and chemosensitivities.Killer cell immunoglobulin-like receptor gene polymorphisms predispose susceptibility to Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in Chinese children.Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML.Advances in immunotherapy for pediatric acute myeloid leukemia.Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice.
P2860
Q26742135-91237E98-EAC4-4189-8C5A-9B244EB81344Q26745906-924D94F0-A98A-46E5-9DFE-57BD319AF983Q27005792-3F997F57-DB90-48B2-BCCA-3396A0325CEAQ33672480-C35469AE-244B-4498-BA8A-0F4EB730C1CDQ33828392-D53F84ED-2AEB-42BF-838D-9FC44284A53DQ34310322-46547934-3BA5-44D0-A6B5-A58059C76F89Q34615804-5F2B00E8-ABDB-40BF-9B19-E43BF6A1638FQ36047157-1F30F25B-1D0B-4CA0-B824-DBFBCD6B7D22Q36125265-E67B45A6-1CD0-45A3-AB99-89CB4083C1CEQ36154501-448EE823-9D10-4B31-8FAC-8B7D10F72AF4Q36410540-F7B0A33C-EFF5-494E-8EA3-2DC8373A58FEQ36830203-98684C1F-4C25-48C6-ADD0-56163319F957Q37018656-4393538E-BD03-45DF-99DB-499E66952642Q37696089-0C0F626F-38A7-4A63-9A47-E37B9212842AQ37709339-723B1AEE-7523-446D-97B5-152AE9649ACEQ37763280-24D73865-2FFA-4CA4-8FD7-613BAC164D6AQ37779043-585A52A4-D61C-4CD1-88E1-5A151F82C6A5Q37885284-03144BF3-3B3A-4BA9-9165-1FDCD3974EDBQ37996816-ADF6F6B8-29C8-48E8-A307-04B6922EEA61Q38036202-B353887C-A5DB-4FCD-974C-17CA8C3E708AQ38081103-6FCCCEED-56B9-417E-9E90-045BEF481D95Q38732620-C49130E0-260F-47FB-89D2-F8E24ECD59A9Q38940720-1ABFA837-9DF7-4ECE-B967-0360F1191FD4Q39190801-FE9524B2-4A58-47FD-8B15-419C796B2822Q40108262-69A31663-B7C9-412D-8171-DABE48119993Q40675376-B1733368-5B90-4121-A69F-DF3964682BD6Q41065103-A82560DF-1A64-40F8-A255-43333C3E7091Q41478903-77EF8E28-E2EC-4FAA-AEED-ADE36A14C160Q43778904-32771EF0-C8DC-4A4E-802A-21A2061B0E2BQ44781881-668585E5-9121-4762-82DA-D06A8A20055EQ47613843-B2ADCCA9-73B1-4FE4-B1DE-70E23C7B5E3FQ47930962-279A4F3D-6531-42D2-8916-7AB8A1173414Q50253847-82553027-ED8B-47CE-93A0-9BF7A9435C23Q53353482-773A0207-802E-4153-972F-F90746A7798B
P2860
Identification of natural killer cell receptor phenotypes associated with leukemia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Identification of natural killer cell receptor phenotypes associated with leukemia.
@en
Identification of natural killer cell receptor phenotypes associated with leukemia.
@nl
type
label
Identification of natural killer cell receptor phenotypes associated with leukemia.
@en
Identification of natural killer cell receptor phenotypes associated with leukemia.
@nl
prefLabel
Identification of natural killer cell receptor phenotypes associated with leukemia.
@en
Identification of natural killer cell receptor phenotypes associated with leukemia.
@nl
P2093
P2860
P356
P1433
P1476
Identification of natural killer cell receptor phenotypes associated with leukemia.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403525
P577
2004-12-01T00:00:00Z
P5875
P6179
1005101796